SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-053969
Filing Date
2023-10-31
Accepted
2023-10-31 17:41:24
Documents
1
Period of Report
2023-10-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5424
  Complete submission text file 0001209191-23-053969.txt   6917
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Issuer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O PAR PHARMACEUTICAL COMPANIES, INC. 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address
Graves Michael (Reporting) CIK: 0001339978 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36306 | Film No.: 231365899